Final Comment

Insomnia is frequent among patients suffering from dementia and probably one of the most disturbing symptoms interfering with the daily care. Insomnia can be associated with other BPSD, and it is not always easy to differentiate which one is the cause and the consequence. There is a dearth of research and guidelines regarding the management of patients with insomnia in dementia.Anyway, adequate knowledge of the patient and their circumstances and effective communication with caregivers are needed.


  • 1. Duffy JF, Zitting KM, Chinoy ED. Aging and circadian rhythms. Sleep Med Clin. 2015;10:423-34.
  • 2. Zdanys KF, Steffens DC. Sleep disturbances in the elderly. Psychiatr Clin N Am. 2015;38:723-41.
  • 3. Porter VR, Buxton WG, Avidan AY. Sleep, cognition and dementia. Curr Psychiatry Rep. 2015;17(12):97.
  • 4. Guarnieri B, Adorni F, Musicco M, Appollonio I, Bonanni E, Caffarra P, et al. Prevalence of sleep disturbances in mild cognitive impairment and dementing disorders: a multicenter Italian clinical cross-sectional study on 431 patients. Dement Geriatr Cogn Disord. 2012;33(1):50-8.
  • 5. Pistacchi M, Gioulis M, Contin F, Sanson F, Marsala SZ. Sleep disturbance and cognitive disorder: epidemiological analysis in a cohort of 263 patients. Neurol Sci. 2014;35(12):1955-62.
  • 6. Dauvilliers Y. Insomnia in patients with neurodegenerative conditions. Sleep Med. 2007;8(Suppl 4):S27-34.
  • 7. Jennum P, Santamaria J. Members of the task force. Report of an EFNS task force on management of sleep disorders in neurologic disease (degenerative neurologic disorders and stroke). Eur J Neurol. 2007;14:1189-200.
  • 8. Cipriani G, Lucetti C, Danti S, Nuti A. Sleep disturbances and dementia. Psychogeriatrics. 2015;15(1):65-74.
  • 9. American Academy of Sleep Medicine. International classification of sleep disorders. 3rd ed. Darion: American Academy of Sleep Medicine; 2014.
  • 10. Auger RR, Burgess HJ, Emens JS, Deriy LV, Thomas SM, Sharkey KM. Clinical practice guideline for the treatment of intrinsic circadian rhythm sleep-wake disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular Sleep-Wake Rhythm Disorder (ISWRD). An update for 2015: an American academy of sleep medicine clinical practice guideline. J Clin Sleep Med. 2015;11(10):1199-236.
  • 11. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193-213.
  • 12. Mecacci L, Zani A. Morningness-eveningness preferences and sleep-waking dairy data of morning and evening types in student and worker samples. Ergonomics. 1983;26:1147-53.
  • 13. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540-5.
  • 14. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med. 1999;131:485-91.
  • 15. The IPA complete guides to behavioral and psychological symptoms of Dementia. International Psychogeriatric Association. IPA.
  • 16. Kales HC, Gitlin LN, Lyketsos CG. Assessment and management of behavioral and psychological symptoms of dementia. BMJ. 2015;350:h369. doi:10.1136/bmj.h369.
  • 17. Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5):487-504.
  • 18. Guarnieri B, Musicco M, Caffarra P, Adorni F, Appollonio I, Arnaldi D, et al. Recommendations of the Sleep Study Group of the Italian Dementia Research Association (SINDem) on clinical assessment and management of sleep disorders in individuals with mild cognitive impairment and dementia: a clinical review. Neurol Sci. 2014;35(9):1329-48.
  • 19. McCurry SM, Gibbons LE, Logsdon RG, Vitiello M, Teri L. Training caregivers to change the sleep hygiene practices of patients with dementia: the NITE-AD project. J Am Geriatr Soc. 2003;51(10):1455-60.
  • 20. Shub D, Darvishi R, Kunik ME. Non-pharmacologic treatment of insomnia in persons with dementia. Geriatrics. 2009;64(2):22-6.
  • 21. McCurry SM, Pike KC, Vitiello MV, Logsdon RG, Larson EB, Teri L. Increasing walking and bright light exposure to improve sleep in community-dwelling persons with Alzheimer’s disease: results of a randomized, controlled trial. J Am Geriatr Soc. 2011;59(8):1393-402.
  • 22. Forbes D, Blake CM, Thiessen EJ, Peacock S, Hawranik P. Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia. Cochrane Database Syst Rev. 2014;2:CD003946. doi: 10.1002/14651858. CD003946.pub4.
  • 23. Cross N, Terpening Z, Rogers NL, Duffy SL, Hickie IB, Lewis SJ, Naismith SL. Napping in older people ‘at risk’ of dementia: relationships with depression, cognition, medical burden and sleep quality. J Sleep Res. 2015;24(5):494-502.
  • 24. McCleery J, Cohen DA, Sharpley AL. Pharmacotherapies for sleep disturbances in Alzheimer’s disease. Cochrane Database Syst Rev. 2014;3:CD009178. doi:10.1002/14651858.CD009178. pub2.
  • 25. Salami O, Lyketsos C, Rao V. Treatment of sleep disturbance in Alzheimer’s dementia. Int J Geriatr Psychiatry. 2011;26(8):771-82.
  • 26. Seppi K, Weintraub D, Coelho M, Perez-Lloret S, Fox SH, Katzenschlager R, et al. The movement disorder society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson’s disease. Mov Disord. 2011;26(Suppl 3):S42-80.
  • 27. Ravona-Springer R, Davidson M. Considerations in psychotropic treatments in dementia-can polypharmacy be avoided? Int J Neuropsychopharmacol. 2014;17(7):1107-17.
  • 28. Defrancesco M, Marksteiner J, Fleischhacker WW, Blasko I. Use of Benzodiazepines in Alzheimer’s disease: a systematic review of literature. Int J Neuropsychopharmacol. 2015;18(10):pyv055.
  • 29. Camargos EF, Louzada LL, Quintas JL, Naves JO, Louzada FM, Nobrega OT. Trazodone improves sleep parameters in Alzheimer disease patients: a randomized, double-blind, and placebo-controlled study. Am J Geriatr Psychiatry. 2014;22(12):1565-74.
  • 30. Dolder CR, Nelson MH, Iler CA. The effects of mirtazapine on sleep in patients with major depressive disorder. Ann Clin Psychiatry. 2012;24(3):215-24.
  • 31. Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, McGuire H, et al. MANGA (Meta-Analysis of New Generation Antidepressants) Study Group. Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis. CNS Drugs. 2010;24(1):35-53.
  • 32. Singer C, Tractenberg RE, Kaye J, Schafer K, Gamst A, Grundman M, et al. Alzheimer’s Disease Cooperative Study. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer’s disease. Sleep. 2003;26(7):893-901.
  • 33. Xu J, Wang LL, Dammer EB, Li CB, Xu G, Chen SD, Wang G. Melatonin for sleep disorders and cognition in dementia: a meta-analysis of randomized controlled trials. Am J Alzheimers Dis Other Demen. 2015;30(5):439-47.
< Prev   CONTENTS   Source   Next >